nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—CCND1—blood vessel—vascular cancer	0.0336	0.193	CbGeAlD
Arsenic trioxide—TXNRD1—PPARA activates gene expression—WWTR1—vascular cancer	0.0308	0.0373	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—WWTR1—vascular cancer	0.0302	0.0365	CbGpPWpGaD
Arsenic trioxide—MAPK3—blood vessel—vascular cancer	0.025	0.144	CbGeAlD
Arsenic trioxide—JUN—TGF-beta Receptor Signaling—TFE3—vascular cancer	0.0238	0.0288	CbGpPWpGaD
Arsenic trioxide—AKT1—blood vessel—vascular cancer	0.0236	0.136	CbGeAlD
Arsenic trioxide—MAPK3—TGF-beta Receptor Signaling—TFE3—vascular cancer	0.0222	0.0269	CbGpPWpGaD
Arsenic trioxide—CCND1—Regulation of retinoblastoma protein—MITF—vascular cancer	0.0217	0.0263	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Fatty acid, triacylglycerol, and ketone body metabolism—WWTR1—vascular cancer	0.0208	0.0251	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Selenium Micronutrient Network—HBA1—vascular cancer	0.0206	0.0249	CbGpPWpGaD
Arsenic trioxide—JUN—blood vessel—vascular cancer	0.0206	0.118	CbGeAlD
Arsenic trioxide—CCND1—C-MYB transcription factor network—CD34—vascular cancer	0.0193	0.0233	CbGpPWpGaD
Arsenic trioxide—CCND1—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—vascular cancer	0.0186	0.0225	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling mediated by p38-alpha and p38-beta—MITF—vascular cancer	0.0173	0.0209	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of nuclear SMAD2/3 signaling—TFE3—vascular cancer	0.0172	0.0208	CbGpPWpGaD
Arsenic trioxide—AKT1—AKT phosphorylates targets in the cytosol—TSC2—vascular cancer	0.0171	0.0206	CbGpPWpGaD
Arsenic trioxide—AKT1—Regulation of nuclear SMAD2/3 signaling—TFE3—vascular cancer	0.0165	0.02	CbGpPWpGaD
Arsenic trioxide—JUN—IL6-mediated signaling events—MITF—vascular cancer	0.0136	0.0165	CbGpPWpGaD
Arsenic trioxide—CCND1—cardiac atrium—vascular cancer	0.0136	0.0782	CbGeAlD
Arsenic trioxide—AKT1—IL6-mediated signaling events—MITF—vascular cancer	0.0131	0.0158	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling events mediated by Stem cell factor receptor (c-Kit)—MITF—vascular cancer	0.0123	0.0148	CbGpPWpGaD
Arsenic trioxide—CCND1—Wnt Signaling Pathway Netpath—TSC2—vascular cancer	0.0123	0.0148	CbGpPWpGaD
Arsenic trioxide—JUN—RANKL/RANK Signaling Pathway—MITF—vascular cancer	0.012	0.0145	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling events mediated by Stem cell factor receptor (c-Kit)—MITF—vascular cancer	0.0119	0.0144	CbGpPWpGaD
Arsenic trioxide—AKT1—RANKL/RANK Signaling Pathway—MITF—vascular cancer	0.0115	0.014	CbGpPWpGaD
Arsenic trioxide—MAPK1—cardiac atrium—vascular cancer	0.0114	0.0659	CbGeAlD
Arsenic trioxide—MAPK3—RANKL/RANK Signaling Pathway—MITF—vascular cancer	0.0112	0.0136	CbGpPWpGaD
Arsenic trioxide—AKT1—Kit receptor signaling pathway—MITF—vascular cancer	0.0109	0.0132	CbGpPWpGaD
Arsenic trioxide—MAPK1—RANKL/RANK Signaling Pathway—MITF—vascular cancer	0.0107	0.0129	CbGpPWpGaD
Arsenic trioxide—TXNRD1—cardiac atrium—vascular cancer	0.0107	0.0613	CbGeAlD
Arsenic trioxide—MAPK3—Kit receptor signaling pathway—MITF—vascular cancer	0.0106	0.0128	CbGpPWpGaD
Arsenic trioxide—CCND1—Validated targets of C-MYC transcriptional repression—TSC2—vascular cancer	0.0105	0.0127	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of retinoblastoma protein—MITF—vascular cancer	0.0104	0.0126	CbGpPWpGaD
Arsenic trioxide—IKBKB—RANKL/RANK Signaling Pathway—MITF—vascular cancer	0.0102	0.0123	CbGpPWpGaD
Arsenic trioxide—MAPK3—cardiac atrium—vascular cancer	0.0101	0.0583	CbGeAlD
Arsenic trioxide—MAPK1—Kit receptor signaling pathway—MITF—vascular cancer	0.0101	0.0122	CbGpPWpGaD
Arsenic trioxide—AKT1—cardiac atrium—vascular cancer	0.00955	0.055	CbGeAlD
Arsenic trioxide—AKT1—FSH signaling pathway—TSC2—vascular cancer	0.0095	0.0115	CbGpPWpGaD
Arsenic trioxide—MAPK3—FSH signaling pathway—TSC2—vascular cancer	0.00922	0.0112	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—vascular cancer	0.00891	0.0108	CbGpPWpGaD
Arsenic trioxide—MAPK1—FSH signaling pathway—TSC2—vascular cancer	0.00877	0.0106	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.00851	0.0103	CbGpPWpGaD
Arsenic trioxide—JUN—cardiac atrium—vascular cancer	0.00831	0.0479	CbGeAlD
Arsenic trioxide—TXNRD1—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	0.00827	0.01	CbGpPWpGaD
Arsenic trioxide—JUN—Myometrial Relaxation and Contraction Pathways—CALD1—vascular cancer	0.00777	0.0094	CbGpPWpGaD
Arsenic trioxide—AKT1—TOR Signaling—TSC2—vascular cancer	0.00755	0.00914	CbGpPWpGaD
Arsenic trioxide—AKT1—Wnt Signaling Pathway Netpath—TSC2—vascular cancer	0.00563	0.00681	CbGpPWpGaD
Arsenic trioxide—CYP1A1—PPARA activates gene expression—WWTR1—vascular cancer	0.00541	0.00654	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—WWTR1—vascular cancer	0.00529	0.0064	CbGpPWpGaD
Arsenic trioxide—CCND1—Integrated Breast Cancer Pathway—TSC2—vascular cancer	0.00522	0.00632	CbGpPWpGaD
Arsenic trioxide—MAPK1—Wnt Signaling Pathway Netpath—TSC2—vascular cancer	0.00519	0.00628	CbGpPWpGaD
Arsenic trioxide—AKT1—mTOR signaling pathway—TSC2—vascular cancer	0.00465	0.00563	CbGpPWpGaD
Arsenic trioxide—MAPK3—mTOR signaling pathway—TSC2—vascular cancer	0.00451	0.00546	CbGpPWpGaD
Arsenic trioxide—AKT1—AMPK Signaling—TSC2—vascular cancer	0.00449	0.00543	CbGpPWpGaD
Arsenic trioxide—MAPK1—mTOR signaling pathway—TSC2—vascular cancer	0.00429	0.00519	CbGpPWpGaD
Arsenic trioxide—IKBKB—mTOR signaling pathway—TSC2—vascular cancer	0.00411	0.00497	CbGpPWpGaD
Arsenic trioxide—ABCB1—blood vessel—vascular cancer	0.00402	0.0232	CbGeAlD
Arsenic trioxide—AKT1—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.00391	0.00473	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.00379	0.00459	CbGpPWpGaD
Arsenic trioxide—AKT1—Constitutive PI3K/AKT Signaling in Cancer—TSC2—vascular cancer	0.00376	0.00455	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—WWTR1—vascular cancer	0.00368	0.00446	CbGpPWpGaD
Arsenic trioxide—MAPK3—IRS-mediated signalling—TSC2—vascular cancer	0.00368	0.00446	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—WWTR1—vascular cancer	0.00365	0.00441	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways in Glioblastoma—TSC2—vascular cancer	0.00361	0.00436	CbGpPWpGaD
Arsenic trioxide—MAPK3—IRS-related events—TSC2—vascular cancer	0.00358	0.00434	CbGpPWpGaD
Arsenic trioxide—MAPK3—IRS-related events triggered by IGF1R—TSC2—vascular cancer	0.00355	0.0043	CbGpPWpGaD
Arsenic trioxide—MAPK1—IRS-mediated signalling—TSC2—vascular cancer	0.0035	0.00424	CbGpPWpGaD
Arsenic trioxide—MAPK3—Insulin receptor signalling cascade—TSC2—vascular cancer	0.00346	0.00418	CbGpPWpGaD
Arsenic trioxide—MAPK3—IGF1R signaling cascade—TSC2—vascular cancer	0.00346	0.00418	CbGpPWpGaD
Arsenic trioxide—MAPK1—IRS-related events—TSC2—vascular cancer	0.00341	0.00412	CbGpPWpGaD
Arsenic trioxide—AKT1—PI-3K cascade—TSC2—vascular cancer	0.00339	0.0041	CbGpPWpGaD
Arsenic trioxide—MAPK1—IRS-related events triggered by IGF1R—TSC2—vascular cancer	0.00338	0.00409	CbGpPWpGaD
Arsenic trioxide—AKT1—PI3K/AKT activation—TSC2—vascular cancer	0.00331	0.004	CbGpPWpGaD
Arsenic trioxide—MAPK1—Insulin receptor signalling cascade—TSC2—vascular cancer	0.00329	0.00398	CbGpPWpGaD
Arsenic trioxide—MAPK1—IGF1R signaling cascade—TSC2—vascular cancer	0.00329	0.00398	CbGpPWpGaD
Arsenic trioxide—AKT1—GAB1 signalosome—TSC2—vascular cancer	0.00328	0.00397	CbGpPWpGaD
Arsenic trioxide—AKT1—Role of LAT2/NTAL/LAB on calcium mobilization—TSC2—vascular cancer	0.00321	0.00388	CbGpPWpGaD
Arsenic trioxide—CYP1A1—cardiac atrium—vascular cancer	0.00313	0.018	CbGeAlD
Arsenic trioxide—MAPK3—Signaling by Insulin receptor—TSC2—vascular cancer	0.00287	0.00348	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by Insulin receptor—TSC2—vascular cancer	0.00273	0.00331	CbGpPWpGaD
Arsenic trioxide—JUN—Direct p53 effectors—TSC2—vascular cancer	0.00265	0.00321	CbGpPWpGaD
Arsenic trioxide—JUN—BDNF signaling pathway—TSC2—vascular cancer	0.00259	0.00314	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by SCF-KIT—TSC2—vascular cancer	0.00253	0.00307	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Breast Cancer Pathway—TSC2—vascular cancer	0.0025	0.00302	CbGpPWpGaD
Arsenic trioxide—AKT1—BDNF signaling pathway—TSC2—vascular cancer	0.00249	0.00301	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by SCF-KIT—TSC2—vascular cancer	0.00246	0.00297	CbGpPWpGaD
Arsenic trioxide—AKT1—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.00242	0.00293	CbGpPWpGaD
Arsenic trioxide—MAPK3—BDNF signaling pathway—TSC2—vascular cancer	0.00242	0.00292	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Breast Cancer Pathway—TSC2—vascular cancer	0.0024	0.0029	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by ERBB4—TSC2—vascular cancer	0.00239	0.00289	CbGpPWpGaD
Arsenic trioxide—JUN—Insulin Signaling—TSC2—vascular cancer	0.00238	0.00288	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	0.00236	0.00285	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.00235	0.00284	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by SCF-KIT—TSC2—vascular cancer	0.00234	0.00283	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by ERBB4—TSC2—vascular cancer	0.00231	0.0028	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—WWTR1—vascular cancer	0.0023	0.00278	CbGpPWpGaD
Arsenic trioxide—MAPK1—BDNF signaling pathway—TSC2—vascular cancer	0.0023	0.00278	CbGpPWpGaD
Arsenic trioxide—AKT1—Insulin Signaling—TSC2—vascular cancer	0.00229	0.00277	CbGpPWpGaD
Arsenic trioxide—AKT1—Downstream signal transduction—TSC2—vascular cancer	0.00228	0.00276	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by FGFR—TSC2—vascular cancer	0.00227	0.00274	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by ERBB2—TSC2—vascular cancer	0.00226	0.00273	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 signaling—TSC2—vascular cancer	0.00224	0.00272	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.00224	0.00271	CbGpPWpGaD
Arsenic trioxide—MAPK3—Insulin Signaling—TSC2—vascular cancer	0.00222	0.00269	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—TSC2—vascular cancer	0.00221	0.00268	CbGpPWpGaD
Arsenic trioxide—AKT1—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.00221	0.00268	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signal transduction—TSC2—vascular cancer	0.00221	0.00267	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB4—TSC2—vascular cancer	0.0022	0.00266	CbGpPWpGaD
Arsenic trioxide—IKBKB—BDNF signaling pathway—TSC2—vascular cancer	0.0022	0.00266	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR—TSC2—vascular cancer	0.0022	0.00266	CbGpPWpGaD
Arsenic trioxide—JUN—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.0022	0.00266	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by ERBB2—TSC2—vascular cancer	0.00219	0.00265	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 signaling—TSC2—vascular cancer	0.00218	0.00263	CbGpPWpGaD
Arsenic trioxide—MAPK1—Insulin Signaling—TSC2—vascular cancer	0.00211	0.00256	CbGpPWpGaD
Arsenic trioxide—AKT1—DAP12 interactions—TSC2—vascular cancer	0.00211	0.00256	CbGpPWpGaD
Arsenic trioxide—AKT1—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.00211	0.00256	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by FGFR in disease—TSC2—vascular cancer	0.00211	0.00256	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signal transduction—TSC2—vascular cancer	0.0021	0.00254	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by EGFR—TSC2—vascular cancer	0.00209	0.00253	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR—TSC2—vascular cancer	0.00209	0.00253	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB2—TSC2—vascular cancer	0.00208	0.00252	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.00207	0.00251	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 signaling—TSC2—vascular cancer	0.00207	0.00251	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by PDGF—TSC2—vascular cancer	0.00207	0.0025	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—HBA1—vascular cancer	0.00206	0.0025	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR in disease—TSC2—vascular cancer	0.00205	0.00248	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 interactions—TSC2—vascular cancer	0.00205	0.00248	CbGpPWpGaD
Arsenic trioxide—MAPK3—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.00205	0.00248	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR—TSC2—vascular cancer	0.00203	0.00246	CbGpPWpGaD
Arsenic trioxide—IKBKB—Insulin Signaling—TSC2—vascular cancer	0.00202	0.00245	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.00201	0.00243	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by PDGF—TSC2—vascular cancer	0.002	0.00242	CbGpPWpGaD
Arsenic trioxide—AKT1—B Cell Activation—TSC2—vascular cancer	0.00195	0.00236	CbGpPWpGaD
Arsenic trioxide—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.00195	0.00236	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR in disease—TSC2—vascular cancer	0.00195	0.00236	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—TSC2—vascular cancer	0.00195	0.00236	CbGpPWpGaD
Arsenic trioxide—MAPK1—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.00195	0.00236	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR—TSC2—vascular cancer	0.00193	0.00234	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.00191	0.00232	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by PDGF—TSC2—vascular cancer	0.00191	0.00231	CbGpPWpGaD
Arsenic trioxide—AKT1—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.00187	0.00226	CbGpPWpGaD
Arsenic trioxide—IKBKB—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.00186	0.00226	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD34—vascular cancer	0.00182	0.0022	CbGpPWpGaD
Arsenic trioxide—MAPK3—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.00181	0.0022	CbGpPWpGaD
Arsenic trioxide—MAPK1—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.00173	0.00209	CbGpPWpGaD
Arsenic trioxide—IKBKB—B Cell Activation—TSC2—vascular cancer	0.00173	0.00209	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—WWTR1—vascular cancer	0.00162	0.00197	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD34—vascular cancer	0.00161	0.00194	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—WWTR1—vascular cancer	0.00158	0.00191	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—WWTR1—vascular cancer	0.00151	0.00183	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—WWTR1—vascular cancer	0.00146	0.00177	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—WWTR1—vascular cancer	0.00145	0.00176	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—TSC2—vascular cancer	0.00144	0.00174	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—TSC2—vascular cancer	0.0014	0.00169	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—WWTR1—vascular cancer	0.00139	0.00168	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—TSC2—vascular cancer	0.00133	0.00161	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—TSC2—vascular cancer	0.00127	0.00154	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—WWTR1—vascular cancer	0.00126	0.00153	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD34—vascular cancer	0.00115	0.00139	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD34—vascular cancer	0.0011	0.00134	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—WWTR1—vascular cancer	0.0011	0.00133	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD34—vascular cancer	0.00107	0.0013	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—WWTR1—vascular cancer	0.00106	0.00128	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—WWTR1—vascular cancer	0.00105	0.00127	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—WWTR1—vascular cancer	0.00102	0.00124	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD34—vascular cancer	0.00102	0.00123	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—WWTR1—vascular cancer	0.000975	0.00118	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD34—vascular cancer	0.000974	0.00118	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—WWTR1—vascular cancer	0.000933	0.00113	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—TSC2—vascular cancer	0.000854	0.00103	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—TSC2—vascular cancer	0.000821	0.000993	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—TSC2—vascular cancer	0.000796	0.000963	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—TSC2—vascular cancer	0.000788	0.000953	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—TSC2—vascular cancer	0.000757	0.000916	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—TSC2—vascular cancer	0.000724	0.000877	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—HBA1—vascular cancer	0.000707	0.000855	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—TSC2—vascular cancer	0.000696	0.000842	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TSC2—vascular cancer	0.000673	0.000814	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—WWTR1—vascular cancer	0.000647	0.000782	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—HBA1—vascular cancer	0.000588	0.000711	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—WWTR1—vascular cancer	0.000516	0.000625	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—TSC2—vascular cancer	0.000497	0.000602	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—TSC2—vascular cancer	0.000478	0.000578	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—TSC2—vascular cancer	0.000464	0.000561	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TSC2—vascular cancer	0.000441	0.000534	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—TSC2—vascular cancer	0.000441	0.000534	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TSC2—vascular cancer	0.000428	0.000518	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—TSC2—vascular cancer	0.000422	0.000511	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TSC2—vascular cancer	0.000407	0.000493	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—HBA1—vascular cancer	0.000362	0.000438	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TSC2—vascular cancer	0.000322	0.000389	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—WWTR1—vascular cancer	0.000318	0.000385	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TSC2—vascular cancer	0.000309	0.000374	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TSC2—vascular cancer	0.0003	0.000363	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—HBA1—vascular cancer	0.000289	0.00035	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TSC2—vascular cancer	0.000285	0.000345	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TSC2—vascular cancer	0.000273	0.00033	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—HBA1—vascular cancer	0.000178	0.000216	CbGpPWpGaD
